Search Results - "HANTSBARGER, G" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet glycoprotein IIb/IIIa Receptor Blockade with oral xemilofiban: Results of a multicenter, placebo-controlled, randomized Trial

Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet glycoprotein IIb/IIIa Receptor Blockade with oral xemilofiban: Results of a multicenter, placebo-controlled, randomized Trial

by KEREIAKES, D. J, KLEIMAN, N. S, HANTSBARGER, G. L, BRYZINSKI, B, TOPOL, E. J, FERGUSON, J. J, ZAKI MASUD, A. R, BRODERICK, T. M, ABBOTTSMITH, C. W, RUNYON, J. P, ANDERSON, L. C, ANDERS, R. J, DREILING, R. J
Published in Circulation (New York, N.Y.) (29.09.1998)

Get full text

Journal Article

INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn’s Disease Treated in the ADMIRE-CD Trial

INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn’s Disease Treated in the ADMIRE-CD Trial

by Panés, Julian, Bouma, Gerd, Ferrante, Marc, Kucharzik, Torsten, Nachury, Maria, de la Portilla de Juan, Fernando, Reinisch, Walter, Selvaggi, Francesco, Tschmelitsch, Jörg, Brett, Neil R, Ladouceur, Martin, Binek, Matthias, Hantsbarger, Gary, Campbell-Hill, Sarah, Karki, Chitra, Buskens, Christianne
Published in Inflammatory bowel diseases (02.11.2022)

Get full text

Journal Article

P340 Real-world treatment patterns and recurrence rates of rectovaginal fistulas in patients with Crohn’s disease: A retrospective cohort database analysis

P340 Real-world treatment patterns and recurrence rates of rectovaginal fistulas in patients with Crohn’s disease: A retrospective cohort database analysis

by Karki, C, Latremouille-Viau, D, Gilaberte, I, Hantsbarger, G, Romdhani, H, Lightner, A
Published in Journal of Crohn's and colitis (27.05.2021)

Get full text

Journal Article

DOP57 Predictive modelling to examine long term treatment effectiveness of darvadstrocel in patients with complex perianal fistulas in Crohn’s Disease

DOP57 Predictive modelling to examine long term treatment effectiveness of darvadstrocel in patients with complex perianal fistulas in Crohn’s Disease

by Maruszczak, M, Genenz, K, Turkstra, E, Fenu, E, Hantsbarger, G, Gilaberte, I, Karki, C, Panes, J
Published in Journal of Crohn's and colitis (27.05.2021)

Get full text

Journal Article

EE215 Higher Work Impairment and Increased Healthcare Resource Utilization in Patients with Crohn's Perianal Fistula: Results from a Global Burden of Illness Study

EE215 Higher Work Impairment and Increased Healthcare Resource Utilization in Patients with Crohn's Perianal Fistula: Results from a Global Burden of Illness Study

by Karki, C, Geransar, P, Hantsbarger, G, Lee, K, Perovic, M, Raven, L, Sajak-Szczerba, M, Sharpe, E, Silber, A, Tozer, P
Published in Value in health (01.07.2022)

Get full text

Journal Article

DOP005 Safety of vedolizumab in patients naïve to treatment with TNF antagonists compared with patients with prior use of TNF antagonists

DOP005 Safety of vedolizumab in patients naïve to treatment with TNF antagonists compared with patients with prior use of TNF antagonists

by Cohen, R, Bhayat, F, Hantsbarger, G, Blake, A, Vermeire, S
Published in Journal of Crohn's and colitis (16.01.2018)

Get full text

Journal Article

P603 INSPIRE: 6-month interim analysis from an observational post-marketing registry on the effectiveness and safety of darvadstrocel in patients with Crohn’s disease and complex perianal fistulas

P603 INSPIRE: 6-month interim analysis from an observational post-marketing registry on the effectiveness and safety of darvadstrocel in patients with Crohn’s disease and complex perianal fistulas

by Zmora, O, Baumgart, D C, Faubion, W, Ferrante, M, Gecse, K, Genestin, E, Geransar, P, Hantsbarger, G, Karki, C, Tozer, P, Panés, J
Published in Journal of Crohn's and colitis (21.01.2022)

Get full text

Journal Article

P315 High symptom burden and impact on health-related quality of life in patients with Crohn’s perianal fistulas: results from a global burden of illness study

P315 High symptom burden and impact on health-related quality of life in patients with Crohn’s perianal fistulas: results from a global burden of illness study

by Karki, C, Sharpe, E, Hantsbarger, G, Lee, K, Perovic, M, Raven, L, Sajak-Szczerba, M, Silber, A, Yoon, A, Tozer, P
Published in Journal of Crohn's and colitis (21.01.2022)

Get full text

Journal Article

P585 Examining faecal incontinence and its impact on health-related quality of life in patients with Crohn’s perianal fistulas: results from a multi-country burden of illness study

P585 Examining faecal incontinence and its impact on health-related quality of life in patients with Crohn’s perianal fistulas: results from a multi-country burden of illness study

by Karki, C, Athavale, A, Hantsbarger, G, Lee, K, Milicevic, S, Perovic, M, Raven, L, Sajak-Szczerba, M, Sharpe, E, Tozer, P
Published in Journal of Crohn's and colitis (21.01.2022)

Get full text

Journal Article

P516 Discrete choice experiment to examine patient preferences for surgical interventions in patients with Crohn’s perianal fistulas: results from a global burden of illness study

P516 Discrete choice experiment to examine patient preferences for surgical interventions in patients with Crohn’s perianal fistulas: results from a global burden of illness study

by Karki, C, Athavale, A, Hantsbarger, G, Lee, K, Milicevic, S, Perovic, M, Raven, L, Sajak-Szczerba, M, Abilash, V, Tozer, P
Published in Journal of Crohn's and colitis (21.01.2022)

Get full text

Journal Article

P724 Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data

P724 Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data

by Card, T, Ungaro, R, Bhayat, F, Blake, A, Hantsbarger, G, Travis, S
Published in Journal of Crohn's and colitis (25.01.2019)

Get full text

Journal Article

Ranibizumab for treatment of neovascular age-related macular degeneration : A phase I/II multicenter, controlled, multidose study

Ranibizumab for treatment of neovascular age-related macular degeneration : A phase I/II multicenter, controlled, multidose study

by HEIER, Jeffrey S, ANTOSZYK, Andrew N, SHAMS, Naveed, PAVAN, Peter Reed, LEFF, Steven R, ROSENFELD, Philip J, CIULLA, Thomas A, DREYER, Richard F, GENTILE, Ronakl C, SY, Judy P, HANTSBARGER, Gary
Published in Ophthalmology (Rochester, Minn.) (01.04.2006)

Get full text

Journal Article

Tolerability and Efficacy of Multiple Escalating Doses of Ranibizumab (Lucentis) for Neovascular Age-Related Macular Degeneration

Tolerability and Efficacy of Multiple Escalating Doses of Ranibizumab (Lucentis) for Neovascular Age-Related Macular Degeneration

by Rosenfeld, Philip J., Heier, Jeffrey S., Hantsbarger, Gary, Shams, Naveed
Published in Ophthalmology (Rochester, Minn.) (01.04.2006)

Get full text

Journal Article

P527 Investigating fatigue in vedolizumab-treated patients with ulcerative colitis or Crohn’s disease from a Belgian registry

P527 Investigating fatigue in vedolizumab-treated patients with ulcerative colitis or Crohn’s disease from a Belgian registry

by Louis, E, Muls, V, Bossuyt, P, Colard, A, Nakad, A, Baert, D, Mana, F, Caenepeel, P, Vanden Branden, S, Vermeire, S, D’Heygere, F, Strubbe, B, Cremer, A, Setakhr, V, Baert, F, Vijverman, A, Coenegrachts, J L, Flamme, F, Hantson, A, Bennett, D, Van Gassen, G, Hantsbarger, G
Published in Journal of Crohn's and colitis (27.05.2021)

Get full text

Journal Article

P600 Vedolizumab dose optimisation: Findings from a Belgian registry

P600 Vedolizumab dose optimisation: Findings from a Belgian registry

by Louis, E, Muls, V, Bossuyt, P, Colard, A, Nakad, A, Baert, D, Mana, F, Caenepeel, P, Vanden Branden, S, Vermeire, S, D’Heygere, F, Strubbe, B, Cremer, A, Coche, J C, Setakhr, V, Baert, F, Vijverman, A, Coenegrachts, J L, Flamme, F, Hantson, A, Wijnen, K, Piters, E, Hantsbarger, G, Dolin, P
Published in Journal of Crohn's and colitis (15.01.2020)

Get full text

Journal Article

686 Randomised, double-blind, placebo-controlled study to assess the ocular safety of mirabegron in normotensive IOP research subjects

686 Randomised, double-blind, placebo-controlled study to assess the ocular safety of mirabegron in normotensive IOP research subjects

by Martin, N, Lewis, R.A, Vogel, R, Sheth, N, Sargent, B, Swearingen, D, Rasmussen, S, Hantsbarger, G, Novack, G.D
Published in European urology supplements : official journal of the European Association of Urology (01.02.2012)

Get full text

Journal Article

P131 Effectiveness and safety of vedolizumab maintenance therapy for inflammatory bowel disease: findings from a Belgian registry

P131 Effectiveness and safety of vedolizumab maintenance therapy for inflammatory bowel disease: findings from a Belgian registry

by Louis, E, Muls, V, Bossuyt, P, Colard, A, Nakad, A, Baert, D, Mana, F, Caenepeel, P, Vanden Branden, S, Vermeire, S, D’Heygere, F, Strubbe, B, Cremer, A, Coche, J-C, Setakhr, V, Baert, F, Vijverman, A, Coenegrachts, J L, Flamme, F, Hantson, A, Wijnen, K, Piters, E, Hantsbarger, G, Wan, F, Jiang, B, Dolin, P
Published in Journal of Crohn's and colitis (25.01.2019)

Get full text

Journal Article

Effects of misoprostol on the pharmacokinetics of indomethacin in human volunteers

Effects of misoprostol on the pharmacokinetics of indomethacin in human volunteers

by Rainsford, K D, James, C, Hunt, R H, Stetsko, P I, Rischke, J A, Karim, A, Nicholson, P A, Smith, M, Hantsbarger, G
Published in Clinical pharmacology and therapeutics (01.04.1992)

Get more information

Journal Article

Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment

Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment

by KEREIAKES, D. J, KLEIMAN, N, FERGUSON, J. J, RUNYON, J. P, BRODERICK, T. M, HIGBY, N. A, MARTIN, L. H, HANTSBARGER, G, MCDONALD, S, ANDERS, R. J
Published in Circulation (New York, N.Y.) (19.08.1997)

Get full text

Journal Article

Differential dose-response to oral xemilofiban after antecedent intravenous abciximab : Administration for complex coronary intervention

Differential dose-response to oral xemilofiban after antecedent intravenous abciximab : Administration for complex coronary intervention

by KEREIAKES, D. J, RUNYON, J. P, KLEIMAN, N. S, HIGBY, N. A, ANDERSON, L. C, HANTSBARGER, G, MCDONALD, S, ANDERS, R. J
Published in Circulation (New York, N.Y.) (01.09.1996)

Get full text

Journal Article